Research Methods:
Gale Business Insights: https://go-gale-com.remote.baruch.cuny.edu
-​ You can use the company history to write the company background and the
SWOT analysis shows and explains the company strengths and weaknesses, etc.
-​ You can get a hint of the other company by looking at the company overview.
Factiva: https://global-factiva-com.remote.baruch.cuny.edu
-​ You can use the snapshot overview to provide the financial information and the
graph to see stock prizes.
Market Atlas: https://marketatlas-mergent-com.remote.baruch.cuny.edu
-​ You can see the financial section to see and compare the company revenue within
each year and the overview to see the stock prices per year.
IBIS world:
https://my-ibisworld-com.remote.baruch.cuny.edu/us/en/industry/32541a/performance#pe
rformance_performance-snapshot
-​ You can find many companies’ market share and current performance for many
brand name pharmaceutical manufacturers in the US.
Yahoo Finance: https://finance.yahoo.com/quote/PFE/
-​ You can use these to find the company stock price change detailedly within one
year.
Article:
https://www.marketbeat.com/stock-ideas/pfizer-is-locking-in-new-growth-through-a-new
-acquisition/
-​ This article is used as the current event and some recent changes Pfizer
announced.
https://www.kff.org/medicare/faqs-about-the-inflation-reduction-acts-medicare-drug-pric
e-negotiation-program/
-​ This article talks about the Inflation Reduction Act of 2022. I use this as an event
that can affect Pfizer stock price.
Part 2
Current Events/News:
A current event is Pfizer's announcement to acquire Metsera, an obesity treatment
company, and enter the obesity drug industry on September 26, 2025. It’s an investment worth
over 4.9billion to 7.3billion(Gabriel Osorio-Mazill). This new business could lead to an
increased stock price and revenue rate due to the high demand obesity drug. Not only will it
bring in more revenue, but Pfizer also has manufacturing advantages because they already have
many factories and sales networks globally(Gale Business Insights). As a result, this will
diversify their business and make the company more stable by reducing its dependence on
vaccines and other traditional medicines. However, there can still be downsides and risks
because it’s a highly competitive market where there’s other firms that have first mover
advantages, and firms that only specialize in obesity drugs.
​
Pfizer’s three year stock overview peaked on December 14, 2022 with its stock price at
$54.48. It was mostly impacted by the pandemic on the demand for covid vaccine, and
healthcare products. After 2022, the stock price gradually decreased to around $25-$30 and one
of the most recent lowest stock prices was on April 10, 2024 with its stock price at
$21.29(Market Atlas). It’s mostly caused by the declined covid-related revenues. In addition, to
The Inflation Reduction Act of 2022, signed by President Biden to lower the cost of prescription
for people with medicare and reduce drug spending by the government(​​Juliette Cubanski).
Moreover, the discontinuation of weight loss pills in December 2023 because of the negative side
effects of mild gastrointestinal, significant weight loss, and patients struggling to tolerate the
drug(Gale Business Insights). Therefore, these issues and the ongoing political debate all
impacted the stock price of Pfizer.
"Graph Cited: Market Atlas, Key Statistics of Stock Price (3 Years)."
Competitive Analysis:
The three top competitors of Pfizer are Amgen, Gilead Science and AbbVie.
9-26-2025 4:23PM
Company
Pfizer
Amgen
Gilead Science
AbbVie
Stock price
23.76
272.98
112.10
220.61
Market share
11.9%
2%
3.92%
13.4%
Company
Strength
Weakness
Pfizer
-​ Wide range of products (vaccines,
-​ Scattered business
cancer, immunity, rare diseases,
-​ Growth slows down
etc.)
-​ World wide manufacturing and
sales network
after vaccine revenue
declines
-​ Complicated global
supervision
Amgen
-​ Focus on overcoming major
diseases
-​ Advanced genetic science and
-​ Market concentrated
in US
-​ Fierce competition
technology
-​ Innovative ability
Gilead Science
-​ Various diseases (HIV, cancer,
liver disease, etc.)
-​ Strong cooperation resources
(universities/pharmaceutical
-​ Long research and
development cycle
-​ Fierce competition
enterprises)
-​ Global sales network
-​ Transnational manufacturing
Abbvie
-​ Experience in treating complex
diseases
-​ self-built global logistics and sales
-​ Scattered business
-​ Over-reliance on core
products
system
-​ New drug pipeline
-​ Globalization
In many aspects such as product types, global layout, brand influence, and market
channels, Pfizer has its strength and weakness compared to other competitors. In product types,
Pfizer has a wide range of products, such as vaccines, cancer, immune and rare(Gale Business
Insights). However, it makes Pfizer difficult to focus on specific areas. While Pfizer is more
diversified, other companies like Amgen and Gilead Science focus on specific treatment areas.
Pfizer also has strong strength on the global manufacturing and sales network, covering
Asia, Europe, and America. Its global layout is wider than Amgen and Gilead Science, but the
operating costs and policy risks are also greater(Gale Business Insights). Operating in many
countries will increase labor, logistics, taxation and other costs. Different countries' policies, such
as differences in drug approval and medical insurance systems, may also bring greater risks and
adjustment pressure.
In addition, Pfizer is a world known brand, it provides many well-known vaccines like
the covid 19 vaccines, prevnar and major pharmaceutical enterprises. After the pandemic, the
vaccine market fluctuates, which causes loss of income (Factiva). As a result, it will need a new
strategic positioning to let their company maintain a competitive advantage in the market.
Furthermore, Pfizer’s market sales through diverse channels, including hospitals,
pharmacies, government and retail(Gale Business Insights). However, the competition is fierce,
because many companies sell through the same channels, have drugs with the same effect and
compete on price and advertising. For example, Amgen has more advantages in direct sales
because of their direct to consumers channels such as print, television, and online media in the
United States(Gale Business Insights).
1.​ SWOT Analysis
Reference:
https://go-gale-com.remote.baruch.cuny.edu/ps/i.do?p=GBIB&u=cuny_baruch&v=2.1&it=r&id=
AAA000068681&sid=bookmark-GBIB&profileDoc=true
Strengths
Weakness
Strong market position
Product Discontinuation
Focusing on research and
development
Decline in Operational
Performance
Collaborations
Opportunities
Threats
Strategic acquisition
Competitive Environment
New Product Approval
Uncertain R&D Outcomes
Strategic Agreements
Regulatory Oversight